Baptiste Leurent
Papers
1
Total Citations
39
H-Index
1
About
Baptiste Leurent is a leading clinical researcher in urological oncology, with a primary focus on improving functional outcomes following robot-assisted radical prostatectomy (RARP) for localised prostate cancer. His most significant contribution is the landmark NeuroSAFE PROOF trial, a multicentre, patient-blinded, randomised controlled phase 3 study published in 2025. This work rigorously evaluated the NeuroSAFE technique—a standardised intraoperative frozen section analysis designed to guide nerve-sparing during surgery. Leurent’s research demonstrated that NeuroSAFE-guided RARP significantly improves postoperative erectile function and early urinary continence recovery compared to standard RARP, offering a crucial evidence-based advancement in surgical precision. With 39 citations for this seminal paper, his work is already shaping clinical guidelines and surgical practice. By addressing the delicate balance between oncological control and quality of life, Leurent has provided surgeons with a validated tool to preserve neurovascular bundles without compromising cancer clearance. His research stands at the forefront of functional urology, directly impacting the long-term wellbeing of thousands of men undergoing prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1